サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1465815

創薬におけるラボオートメーションの世界市場レポート 2024年

Lab Automation In Drug Discovery Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
創薬におけるラボオートメーションの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

創薬におけるラボオートメーション市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR5.3％で79億6,000万米ドルに成長します。予測期間中に予想される成長は、製薬企業の医薬品パイプラインの拡大、個別化医療と精密治療法の台頭、希少疾患と希少疾病治療薬への注目の高まり、遠隔・分散型臨床試験への需要の高まり、マイクロ流体技術とラボオンチップ技術の出現など、いくつかの要因に起因すると考えられます。予測期間に予想される主な動向には、モジュール式でカスタマイズ可能な自動化ソリューションの普及、データ管理とコラボレーションのためのクラウドベース・プラットフォームの採用、新興国市場での自動化の成長、自動化とデジタル技術を活用したバーチャル創薬企業の台頭、標準化されたプロトコルと相互運用可能なシステムの開発などがあります。これらの要因が総合的に創薬におけるラボオートメーションの成長予測に寄与しています。

精密医療に対する需要の高まりは、創薬におけるラボオートメーション市場の成長を促進すると予想されます。精密医療は、個別化医療としても知られ、遺伝子、環境、ライフスタイルの個人差に基づいて、医療治療と予防戦略を調整します。ラボオートメーションは、研究の加速、実験の再現性の向上、精密医療と創薬手順の効率化において極めて重要な役割を果たしています。これは、ひいては個々の患者に合わせたより効果的な医薬品や診断法の開発につながります。個別化医療連合（PMC）によると、2022年10月には、75,000を超える遺伝子検査製品と300を超える個別化医薬品が市場に出回り、様々なタイプのがん、遺伝的希少疾患、様々な慢性疾患や感染症に対応することが予想されています。精密医療に対する需要の高まりは、創薬におけるラボオートメーション市場の成長を促進する主要な要因です。

創薬におけるラボオートメーション市場で事業を展開する有力企業は、戦略的に先進ソリューション、特に迅速なアイデアからデータへのソリューションの開拓に注力し、競争力を獲得しています。ラピッド・アイデア・ツー・データ・ソリューションとは、個人や組織がアイデアやコンセプトを実用的な洞察やデータ主導の結果に素早く変換できるようにする、合理化されたプロセスやプラットフォームを指します。2022年4月、米国のバイオテクノロジー企業であるStrateos Inc.は、同社のクラウド・ラボ・オートメーション・アズ・ア・サービス・プラットフォームに、低分子化合物探索のためのラピッド・アイデア・ツー・データ・ソリューションを導入しました。医薬品開発における低分子化合物探索のために特別に設計されたこのラボ自動化ツールは、オンデマンドでスケーラブルなStrateos Cloud Lab Automation-as-a-Service Platform上で動作します。このプラットフォームには、23のワークセルと数百の機器を備えたロボットによる自動化がリンクされており、リードの最適化による早期リード創出を促進します。ユーザーは、クラウド上で化合物をデザインし、細胞ベース、生化学的、構造活性相関（SAR）評価など、さまざまな手法で自動的に組み立て、試験することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の創薬におけるラボオートメーション市場：タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 自動液体ハンドラー
  • 自動プレートハンドラー
  • ロボットアーム
  • 自動保管・回収システム
  • その他のタイプ
  • 世界の創薬におけるラボオートメーション市場：コンポーネント別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 機器
  • ソフトウェア
  • サービス
  • 世界の創薬におけるラボオートメーション市場：用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • ハイスループットスクリーニング
  • 化合物管理
  • サンプル調製
  • その他の用途
  • 世界の創薬におけるラボオートメーション市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • バイオテクノロジーと製薬産業
  • 研究機関
  • その他のエンドユーザー

第7章 地域別・国別分析

  • 世界の創薬におけるラボオートメーション市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界の創薬におけるラボオートメーション市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 創薬におけるラボオートメーション市場：競合情勢
  • 創薬におけるラボオートメーション市場：企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Abbott Diagnostics
    • Roche Holdings Inc.
    • Beckman Coulter
    • Siemens Healthineers

第31章 その他の大手企業と革新的企業

  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Endress+Hauser
  • Shimadzu Corporation
  • Waters Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN
  • Beckhoff Automation GmbH & Co. KG
  • Eppendorf AG
  • Tecan Group Ltd.
  • Brooks Automation Inc.
  • Hamilton Company
  • AbCellera Biologics Inc.
  • Hudson Robotics Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r17134

Lab automation in drug discovery refers to the utilization of advanced technologies and robotics to streamline and optimize laboratory processes associated with new drug development and research. This approach aims to significantly improve the efficiency and success rate of drug discovery efforts by automating repetitive tasks and integrating sophisticated instruments and software. Automation in drug discovery laboratories can cover a wide range of activities, from high-throughput screening of compounds to data analysis and interpretation, allowing researchers to focus on more complex and creative aspects of their work.

The primary types of lab automation in drug discovery include automated liquid handlers, automated plate handlers, robotic arms, automated storage and retrieval systems, among others. Automated liquid handlers are machines specifically designed to dispense and handle liquids automatically. They are frequently employed in laboratories for precise and efficient liquid handling tasks such as pipetting and dilution. These automation solutions comprise various components, including instruments, software, and services, and find applications in high-throughput screening, compound management, sample preparation, and other processes. These technologies are utilized by various end-users, including biotechnology and pharmaceutical industries, research institutes, and others.

The lab automation in drug discovery research report is one of a series of new reports from The Business Research Company that provides lab automation in drug discovery market statistics, including the lab automation in drug discovery industry's global market size, regional shares, competitors with lab automation in drug discovery market share, detailed lab automation in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation in drug discovery industry. This lab automation in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lab automation in drug discovery market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.47 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The expansion observed in the historical period can be attributed to several factors, including the increasing complexity of drug discovery processes, a demand for improved efficiency and cost reduction, a growing need for high-throughput screening capabilities, rising labor costs, and the pressure to accelerate drug development timelines. These factors collectively contributed to the growth of lab automation in drug discovery during that timeframe.

The lab automation in drug discovery market size is expected to see strong growth in the next few years. It will grow to $7.96 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be attributed to several factors, including the expansion of drug pipelines among pharmaceutical companies, the rise in personalized medicine and precision therapeutics, an increasing focus on rare diseases and orphan drugs, a growing demand for remote and decentralized clinical trials, and the emergence of microfluidics and lab-on-a-chip technologies. Key trends expected in the forecast period include the proliferation of modular and customizable automation solutions, the adoption of cloud-based platforms for data management and collaboration, the growth of automation in emerging markets, the rise of virtual drug discovery companies leveraging automation and digital technologies, and the development of standardized protocols and interoperable systems. These factors collectively contribute to the projected growth in lab automation in drug discovery.

The growing demand for precision medicine is anticipated to drive the growth of lab automation in the drug discovery market. Precision medicine, also known as personalized medicine, tailors medical treatment and prevention strategies based on individual variability in genes, environment, and lifestyle. Lab automation plays a pivotal role in accelerating research, enhancing experimental repeatability, and improving the efficiency of precision medicine and drug discovery procedures. This, in turn, leads to the development of more effective medicines and diagnostics tailored to individual patients. According to the Personalized Medicine Coalition (PMC) in October 2022, over 75,000 genetic testing products and 300 personalized medicines are expected to be available in the market, catering to individuals with various types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. The rising demand for precision medicine is a key driver propelling the growth of lab automation in the drug discovery market.

Prominent companies operating in the lab automation in the drug discovery market are strategically focusing on developing advanced solutions, particularly rapid idea-to-data solutions, to gain a competitive edge. A rapid idea-to-data solution refers to a streamlined process or platform enabling individuals or organizations to quickly transform ideas or concepts into actionable insights or data-driven results. In April 2022, Strateos Inc., a US-based biotechnology company, introduced a rapid idea-to-data solution for small molecule discovery on its cloud lab automation-as-a-service platform. Specifically designed for small-molecule discovery in drug development, this lab automation tool operates on the on-demand and scalable Strateos Cloud Lab Automation-as-a-Service Platform. The platform includes linked robotic automation with 23 workcells and hundreds of instruments, facilitating early lead generation through lead optimization. Users can design compounds in the cloud and have them automatically assembled and tested using various methods such as cell-based, biochemical, and structured-activity relationship (SAR) assessments.

In March 2023, Brooks Automation, a US-based automation solution company, successfully acquired Aim Lab Automation Technologies Pty Ltd. for an undisclosed amount. This strategic acquisition aims to expand Brooks' presence in clinical diagnostics and drive technological advancements, significantly impacting lab automation in the drug discovery market. Aim Lab Automation Technologies Pty Ltd., based in Australia, provides robotic automation instrumentation and modules, along with automation solutions designed to enhance processes in drug discovery labs.

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

North America was the largest region in the lab automation in drug discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab automation in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab automation in drug discovery market consists of revenues earned by entities by providing services such as compound screening, assay development, high-throughput screening, data analysis, and optimization of drug candidates. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab automation in drug discovery market also includes sales of robotics and automated workstations, screening systems, plate readers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab Automation In Drug Discovery Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lab automation in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lab automation in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lab automation in drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Automated Liquid Handlers; Automated Plate Handlers; Robotic Arms; Automated Storage And Retrieval Systems; Other Types
  • 2) By Component: Instruments; Software; Services
  • 3) By Application: High-Throughput Screening; Compound Management; Sample Preparation; Other Applications
  • 4) By End-User: Biotechnology And Pharmaceutical Industries; Research Institutes; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Diagnostics; Roche Holdings Inc.; Beckman Coulter; Siemens Healthineers
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lab Automation In Drug Discovery Market Characteristics

3. Lab Automation In Drug Discovery Market Trends And Strategies

4. Lab Automation In Drug Discovery Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Lab Automation In Drug Discovery Market Size and Growth

  • 5.1. Global Lab Automation In Drug Discovery Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Lab Automation In Drug Discovery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Lab Automation In Drug Discovery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lab Automation In Drug Discovery Market Segmentation

  • 6.1. Global Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Automated Liquid Handlers
  • Automated Plate Handlers
  • Robotic Arms
  • Automated Storage And Retrieval Systems
  • Other Types
  • 6.2. Global Lab Automation In Drug Discovery Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Software
  • Services
  • 6.3. Global Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • High-Throughput Screening
  • Compound Management
  • Sample Preparation
  • Other Applications
  • 6.4. Global Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biotechnology And Pharmaceutical Industries
  • Research Institutes
  • Other End-Users

7. Lab Automation In Drug Discovery Market Regional And Country Analysis

  • 7.1. Global Lab Automation In Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Lab Automation In Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lab Automation In Drug Discovery Market

  • 8.1. Asia-Pacific Lab Automation In Drug Discovery Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lab Automation In Drug Discovery Market

  • 9.1. China Lab Automation In Drug Discovery Market Overview
  • 9.2. China Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lab Automation In Drug Discovery Market

  • 10.1. India Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lab Automation In Drug Discovery Market

  • 11.1. Japan Lab Automation In Drug Discovery Market Overview
  • 11.2. Japan Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lab Automation In Drug Discovery Market

  • 12.1. Australia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lab Automation In Drug Discovery Market

  • 13.1. Indonesia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lab Automation In Drug Discovery Market

  • 14.1. South Korea Lab Automation In Drug Discovery Market Overview
  • 14.2. South Korea Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lab Automation In Drug Discovery Market

  • 15.1. Western Europe Lab Automation In Drug Discovery Market Overview
  • 15.2. Western Europe Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lab Automation In Drug Discovery Market

  • 16.1. UK Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lab Automation In Drug Discovery Market

  • 17.1. Germany Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lab Automation In Drug Discovery Market

  • 18.1. France Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lab Automation In Drug Discovery Market

  • 19.1. Italy Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lab Automation In Drug Discovery Market

  • 20.1. Spain Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lab Automation In Drug Discovery Market

  • 21.1. Eastern Europe Lab Automation In Drug Discovery Market Overview
  • 21.2. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lab Automation In Drug Discovery Market

  • 22.1. Russia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lab Automation In Drug Discovery Market

  • 23.1. North America Lab Automation In Drug Discovery Market Overview
  • 23.2. North America Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lab Automation In Drug Discovery Market

  • 24.1. USA Lab Automation In Drug Discovery Market Overview
  • 24.2. USA Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lab Automation In Drug Discovery Market

  • 25.1. Canada Lab Automation In Drug Discovery Market Overview
  • 25.2. Canada Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lab Automation In Drug Discovery Market

  • 26.1. South America Lab Automation In Drug Discovery Market Overview
  • 26.2. South America Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lab Automation In Drug Discovery Market

  • 27.1. Brazil Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lab Automation In Drug Discovery Market

  • 28.1. Middle East Lab Automation In Drug Discovery Market Overview
  • 28.2. Middle East Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lab Automation In Drug Discovery Market

  • 29.1. Africa Lab Automation In Drug Discovery Market Overview
  • 29.2. Africa Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lab Automation In Drug Discovery Market Competitive Landscape And Company Profiles

  • 30.1. Lab Automation In Drug Discovery Market Competitive Landscape
  • 30.2. Lab Automation In Drug Discovery Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Diagnostics
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holdings Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Beckman Coulter
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Lab Automation In Drug Discovery Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Agilent Technologies Inc.
  • 31.3. PerkinElmer Inc.
  • 31.4. Endress+Hauser
  • 31.5. Shimadzu Corporation
  • 31.6. Waters Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. QIAGEN
  • 31.9. Beckhoff Automation GmbH & Co. KG
  • 31.10. Eppendorf AG
  • 31.11. Tecan Group Ltd.
  • 31.12. Brooks Automation Inc.
  • 31.13. Hamilton Company
  • 31.14. AbCellera Biologics Inc.
  • 31.15. Hudson Robotics Inc.

32. Global Lab Automation In Drug Discovery Market Competitive Benchmarking

33. Global Lab Automation In Drug Discovery Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lab Automation In Drug Discovery Market

35. Lab Automation In Drug Discovery Market Future Outlook and Potential Analysis

  • 35.1 Lab Automation In Drug Discovery Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Lab Automation In Drug Discovery Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Lab Automation In Drug Discovery Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer